KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nektar Therapeutics (NKTR) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Nektar Therapeutics (NKTR) over the last 16 years, with Q3 2025 value amounting to $5.2 million.

  • Nektar Therapeutics' Other Non-Current Assets fell 8440.08% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 8440.08%. This contributed to the annual value of $4.6 million for FY2024, which is 6.46% up from last year.
  • Latest data reveals that Nektar Therapeutics reported Other Non-Current Assets of $5.2 million as of Q3 2025, which was down 8440.08% from $5.0 million recorded in Q2 2025.
  • Over the past 5 years, Nektar Therapeutics' Other Non-Current Assets peaked at $33.1 million during Q3 2024, and registered a low of $344000.0 during Q2 2021.
  • For the 5-year period, Nektar Therapeutics' Other Non-Current Assets averaged around $4.7 million, with its median value being $2.7 million (2021).
  • In the last 5 years, Nektar Therapeutics' Other Non-Current Assets skyrocketed by 63077.6% in 2024 and then crashed by 8440.08% in 2025.
  • Quarter analysis of 5 years shows Nektar Therapeutics' Other Non-Current Assets stood at $2.7 million in 2021, then fell by 18.19% to $2.2 million in 2022, then skyrocketed by 106.86% to $4.6 million in 2023, then increased by 0.06% to $4.6 million in 2024, then rose by 10.95% to $5.2 million in 2025.
  • Its Other Non-Current Assets stands at $5.2 million for Q3 2025, versus $5.0 million for Q2 2025 and $5.4 million for Q1 2025.